HTLV-I-seronegative, genome-positive adult T-cell leukemia: report of a case.

Abstract:

:An HTLV-I-seronegative case of adult T-cell leukemia (ATL) carrying the HTLV-I genome is reported. Screening serological tests were negative and Western blot analysis revealed only a faint band for HTLV-I p24. Polymerase chain reaction (PCR) disclosed the presence of HTLV-I gag, pol, env, pX, and LTR sequences in the lymph node and peripheral blood. Southern blot analysis revealed a monoclonal integration of HTLV-I in the lymph node and peripheral blood. The tumor cells expressed viral antigens after short-term culture. The clinical course was consistent with ATL in that the patient exhibited hypercalcemia and abnormal lymphocytosis as well as hepatosplenomegaly and lymphadenopathy. We recommend that PCR analysis for HTLV-I be performed even in seronegative cases when ATL is clinically suspected.

journal_name

Am J Hematol

authors

Kubota T,Ikezoe T,Hakoda E,Sawada T,Taguchi H,Miyoshi I

doi

10.1002/(SICI)1096-8652(199610)53:2<133::AID-AJH13

subject

Has Abstract

pub_date

1996-10-01 00:00:00

pages

133-6

issue

2

eissn

0361-8609

issn

1096-8652

pii

10.1002/(SICI)1096-8652(199610)53:2<133::AID-AJH13

journal_volume

53

pub_type

杂志文章
  • Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.

    abstract::Plerixafor, a recently approved peripheral blood progenitor cell mobilizing agent, is often added to granulocyte-colony stimulating factor (G-CSF) to mobilize peripheral blood progenitor cells in patients with lymphoma or myeloma who cannot mobilize enough CD34+ cells with G-CSF alone to undergo autologous stem cell t...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23499

    authors: Smith VR,Popat U,Ciurea S,Nieto Y,Anderlini P,Rondon G,Alousi A,Qazilbash M,Kebriaei P,Khouri I,de Lima M,Champlin R,Hosing C

    更新日期:2013-09-01 00:00:00

  • Localized herpes simplex lymphadenitis mimicking large-cell (Richter's) transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.

    abstract::We report a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who presented with rapid enlargement of a cervical lymph node due to localized herpes simplex lymphadenitis, which was clinically indistinguishable from large cell (Richter's) transformation. The diagnosis was made by excisional...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10006

    authors: Joseph L,Scott MA,Schichman SA,Zent CS

    更新日期:2001-12-01 00:00:00

  • Natural history of acquired immunodeficiency syndrome in hemophilic patients.

    abstract::During the 5-year period from 1981 to 1985, we have observed 8 cases of acquired immunodeficiency syndrome (AIDS) among our 85 patients with hemophilia A. Thus, the prevalence of AIDS with hemophilia A is 9.4% in our patient population. By utilizing stored serum or plasma samples dating back to 1978, antibody against ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830240208

    authors: Kim HC,Nahum K,Raska K Jr,Gocke DJ,Kosmin M,Karp GI,Saidi P

    更新日期:1987-02-01 00:00:00

  • Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.

    abstract::Duvelisib (IPI-145), an oral, dual inhibitor of phosphoinositide-3-kinase (PI3K)-δ and -γ, was evaluated in a Phase 1 study in advanced hematologic malignancies, which included expansion cohorts in relapsed/refractory (RR) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and treatment-naïve (TN) CLL...

    journal_title:American journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1002/ajh.25243

    authors: O'Brien S,Patel M,Kahl BS,Horwitz SM,Foss FM,Porcu P,Jones J,Burger J,Jain N,Allen K,Faia K,Douglas M,Stern HM,Sweeney J,Kelly P,Kelly V,Flinn I

    更新日期:2018-11-01 00:00:00

  • Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease.

    abstract::The acquired JAK2 V617F mutation is common in patients with myeloproliferative neoplasms. We previously showed that JAK2 V617F is also found in coronary patients, most of them affected by coronary atherosclerosis. Peripheral arterial disease (PAD) is another important manifestation of atherosclerosis. However, prevale...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23874

    authors: Muendlein A,Kinz E,Gasser K,Leiherer A,Rein P,Saely CH,Grallert H,Peters A,Fraunberger P,Drexel H,Lang AH

    更新日期:2015-01-01 00:00:00

  • Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations.

    abstract::A small number of thromboembolic events, including deep venous thrombosis and myocardial infarction, have been reported in patients receiving IVIG. These events have primarily occurred in patients receiving high-dose IVIG and have been attributed to an increase in blood viscosity. To test the hypothesis that a procoag...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/1096-8652(200009)65:1<30::aid-ajh5>3.0.co;

    authors: Wolberg AS,Kon RH,Monroe DM,Hoffman M

    更新日期:2000-09-01 00:00:00

  • Treatment of individuals who cannot receive blood products for religious or other reasons.

    abstract::By virtue of their religious principles, Jehovah's Witnesses (JWs) generally object to receiving blood products, raising numerous ethical, legal, and medical challenges for providers who care for these patients, especially in the emergent setting. In this review, we discuss several areas relevant to the care of JWs, i...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.24889

    authors: Scharman CD,Burger D,Shatzel JJ,Kim E,DeLoughery TG

    更新日期:2017-12-01 00:00:00

  • Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature.

    abstract::Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome (HUS) is a recently defined clinical entity. In this paper we have attempted to characterize the natural history and laboratory abnormalities typical of quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome in nine patie...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.2830470407

    authors: Gottschall JL,Neahring B,McFarland JG,Wu GG,Weitekamp LA,Aster RH

    更新日期:1994-12-01 00:00:00

  • Gene therapies for transfusion dependent β-thalassemia: Current status and critical criteria for success.

    abstract::Thalassemia is one of the most prevalent monogenic diseases usually caused by quantitative defects in the production of β-globin leading to severe anemia. Technological advances in genome sequencing, stem cell selection, viral vector development, transduction and gene editing strategies now allow for efficient exvivo ...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.25909

    authors: Soni S

    更新日期:2020-09-01 00:00:00

  • Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculations.

    abstract::The pharmacokinetics of factor VIII were studied in a series of 20 hemophilia-A patients undergoing surgery. Regardless of the type of operation, elimination of factor VIII was shown to be increased only in ten cases (50%) during the post-operative period. In this subgroup of patients, factor VIII half-life, measured ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830300305

    authors: Longo G,Messori A,Morfini M,Baudo F,Ciavarella N,Cinotti S,Filimberti E,Giustarini G,Molinari AC,Ferrini PR

    更新日期:1989-03-01 00:00:00

  • Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.

    abstract::Several studies reported improved outcomes of adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) treated with pediatric-based ALL regimens. This prompted the prospective investigation of a pediatric Augmented Berlin-Frankfurt-Münster (ABFM) regimen, and its comparison with hyper-fractionated cy...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24419

    authors: Rytting ME,Jabbour EJ,Jorgensen JL,Ravandi F,Franklin AR,Kadia TM,Pemmaraju N,Daver NG,Ferrajoli A,Garcia-Manero G,Konopleva MY,Borthakur G,Garris R,Wang S,Pierce S,Schroeder K,Kornblau SM,Thomas DA,Cortes JE,O'Brie

    更新日期:2016-08-01 00:00:00

  • Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.

    abstract::We aimed to determine the survival benefits of chemotherapy (CT) added to radiotherapy (RT) in different risk groups of patients with early-stage extranodal nasal-type NK/T-cell lymphoma (ENKTCL), and to investigate the risk of postponing RT based on induction CT responses. A total of 1360 patients who received RT wit...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/ajh.25878

    authors: Qi SN,Yang Y,Zhang YJ,Huang HQ,Wang Y,He X,Zhang LL,Wu G,Qu BL,Qian LT,Hou XR,Zhang FQ,Qiao XY,Wang H,Li GF,Zhu Y,Cao JZ,Wu JX,Wu T,Zhu SY,Shi M,Xu LM,Yuan ZY,Su H,Song YQ,Zhu J,Hu C,Li YX

    更新日期:2020-09-01 00:00:00

  • Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group.

    abstract::While surgery is commonly required for complications related to hemoglobin SC (HbSC) disease, little is known about the perioperative complications or the indications for preoperative transfusion in this group. We describe the patient characteristics, preoperative transfusion regimens, and outcome in 92 patients with ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199802)57:2<101::aid-ajh2>

    authors: Neumayr L,Koshy M,Haberkern C,Earles AN,Bellevue R,Hassell K,Miller S,Black D,Vichinsky E

    更新日期:1998-02-01 00:00:00

  • Hereditary hemochromatosis and red cell aplasia.

    abstract::A 63-year-old white man with myasthenia gravis and red cell aplasia was found to have hepatic iron overload. The differential diagnosis included hereditary hemochromatosis and secondary iron overload related to red cell aplasia. Family studies of siblings, including HLA typing, initially suggested a diagnosis of secon...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830450314

    authors: Adams PC

    更新日期:1994-03-01 00:00:00

  • Low-dose cytosine arabinoside for treating hypocellular acute leukemia in the elderly.

    abstract::Ten previously untreated elderly patients with hypocellular acute leukemia received a low dose of cytosine arabinoside (Ara-C), 10 mg/m2 injected subcutaneously every 12 hours for 14-28 days. Six patients achieved a complete remission (CR) for periods ranging for 6-23 months (median 8.5 months) and the others had a pa...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章

    doi:10.1002/ajh.2830390111

    authors: Kanamori H,Maruta A,Miyashita H,Harano H,Fukawa H,Matsuzaki M,Motomura S,Mohri H,Kodama F,Okubo T

    更新日期:1992-01-01 00:00:00

  • Mild iron deficiency does not ameliorate the phenotype of a murine erythropoietic protoporphyria model.

    abstract::Reduced ferrochelatase activity in erythropoietic protoporphyria (EPP) causes the accumulation of protoporphyrin IX (PPIX) leading to acute cutaneous photosensitivity and liver injury. Many EPP patients also have a mild hypochromic, microcytic anemia and iron deficiency. Iron deficiency can lead to decreased PPIX accu...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.25743

    authors: Schmidt PJ,Hollowell ML,Fitzgerald K,Butler JS,Fleming MD

    更新日期:2020-05-01 00:00:00

  • Molecular and hematological characterization of HPFH-6/Indian deletion-inversion Ggamma(Agammadeltabeta)0-thalassemia and Ggamma(Agammadeltabeta)0-thalassemia/HbE in Thai patients.

    abstract::The hereditary persistence of fetal hemoglobin (HPFH)-6 is sporadically found in Thailand whereas the deletion-inversion type (G)gamma((A)gamma delta beta)(0)-thalassemia is described among Indians. We report a hitherto un-described case in which these two defects co-segregate. He was a 3-year-old Thai boy who had a f...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10202

    authors: Fucharoen S,Pengjam Y,Surapot S,Fucharoen G,Sanchaisuriya K

    更新日期:2002-10-01 00:00:00

  • Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States.

    abstract::Non-Hodgkin lymphoma arising in the context of immunosuppression is an important adverse outcome after solid organ transplantation. Diffuse large B-cell lymphoma (DLBCL) is the most commonly diagnosed subtype of post-transplantation non-Hodgkin lymphoma, but few studies of transplant recipients have examined subtype-s...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23726

    authors: Gibson TM,Engels EA,Clarke CA,Lynch CF,Weisenburger DD,Morton LM

    更新日期:2014-07-01 00:00:00

  • Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.

    abstract::Over the past 40 years, public health measures such as universal newborn screening, penicillin prophylaxis, vaccinations, and hydroxyurea therapy have led to an impressive decline in sickle cell disease (SCD)-related childhood mortality and SCD-related morbidity in high-income countries. We remain cautiously optimisti...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.24235

    authors: Chaturvedi S,DeBaun MR

    更新日期:2016-01-01 00:00:00

  • Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.

    abstract:OBJECTIVE:To assess the efficacy of intravenous immunoglobulin (IVIG), in comparison with plasma exchange (PE), in the treatment of patients with thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS). DESIGN:Prospective, nonrandomized comparative study. SETTING:Hematology department in a general hos...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830410305

    authors: Finazzi G,Bellavita P,Falanga A,Viero P,Barbui T

    更新日期:1992-11-01 00:00:00

  • Change of enzyme properties caused by cross-linking treatment of human erythrocytes.

    abstract::Aragon et al [4] reported that rat erythrocytes can be cross-linked and permeabilized without significant inactivation or alterations of several enzymes in the glycolytic pathway. If this is the case, in situ kinetic analysis of the red cell enzymes in normal human red cells and abnormal red cells associated with hemo...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830130103

    authors: Ikawa M,Yoshida A

    更新日期:1982-08-01 00:00:00

  • Vitamin E (alpha-tocopherol) does not inhibit platelet stimulation by oxidized low density lipoprotein in vitro.

    abstract::Platelet-rich plasma were treated with increasing concentrations of vitamin E (alpha-tocopherol). Washed platelets were exposed to oxidized low density lipoprotein (LDL) and examined by aggregometry and electron microscopy. The treatment of washed platelets by oxidized LDL induced morphological signs of activation lik...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199903)60:3<242::aid-ajh15

    authors: Szuwart T,Dierichs RB,Zhao B

    更新日期:1999-03-01 00:00:00

  • High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia.

    abstract::Acute myeloid leukemia (AML) with mutated NPM1 is a newly recognized separate entity in the revised 2016 WHO classification, and is associated with a favorable prognosis. While previous studies have evaluated NPM1 in a binary fashion, we recently demonstrated a significant independent negative prognostic effect of hig...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.25544

    authors: Patel SS,Pinkus GS,Ritterhouse LL,Segal JP,Dal Cin P,Restrepo T,Harris MH,Stone RM,Hasserjian RP,Weinberg OK

    更新日期:2019-08-01 00:00:00

  • Venous insufficiency is not the cause of leg ulcers in sickle cell disease.

    abstract::Leg ulcers are a well recognized complication of sickle cell disease that has been attributed to venous insufficiency. We studied 16 patients with sickle cell disease and active ulcers using venous pulse volume recordings and photoplethysmography (Doppler studies). Based on hemodynamic monitoring, all 16 patients exhi...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830370215

    authors: Billett HH,Patel Y,Rivers SP

    更新日期:1991-06-01 00:00:00

  • Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His.

    abstract::Mast cell disease (MCD), a proliferation of mast cells (MC), is occasionally associated with hematologic malignancies. Neoplastic MC have activating c-kit mutations. c-kit is a receptor tyrosine kinase required for the development, proliferation, and survival of MC. Interaction of c-kit with its ligand stem cell facto...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/1096-8652(200012)65:4<307::aid-ajh10>3.0.c

    authors: Pullarkat VA,Pullarkat ST,Calverley DC,Brynes RK

    更新日期:2000-12-01 00:00:00

  • First-line treatment of 102 chronic myeloid leukemia patients with imatinib: a long-term single institution analysis.

    abstract::Imatinib mesylate radically changed the natural history of chronic myeloid leukemia (CML). The recent availability of alternative tyrosine kinase inhibitors (TKIs) renders the clinical management of CML more complex. In this article, we summarize our long-term single institution experience. From 2003 to 2012, 102 pati...

    journal_title:American journal of hematology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/ajh.23804

    authors: Viganò I,Di Giacomo N,Bozzani S,Antolini L,Piazza R,Gambacorti Passerini C

    更新日期:2014-10-01 00:00:00

  • Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.

    abstract::The objective of this case-matched study was to compare the efficacy and toxicity of the addition of clarithromycin (Biaxin) to lenalidomide/low-dose dexamethasone (BiRd) vs. lenalidomide/low-dose dexamethasone (Rd) for newly diagnosed myeloma. Data from 72 patients treated at the New York Presbyterian Hospital-Cornel...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/ajh.21777

    authors: Gay F,Rajkumar SV,Coleman M,Kumar S,Mark T,Dispenzieri A,Pearse R,Gertz MA,Leonard J,Lacy MQ,Chen-Kiang S,Roy V,Jayabalan DS,Lust JA,Witzig TE,Fonseca R,Kyle RA,Greipp PR,Stewart AK,Niesvizky R

    更新日期:2010-09-01 00:00:00

  • Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia.

    abstract::Heparin-induced thrombocytopenia is a rare but severe complication of heparin therapy that can result in severe venous or arterial thromboembolic events and whose treatment remains partially unanswered. Recombinant hirudin is potentially effective as an antithrombotic treatment in the management of heparin-induced thr...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830500105

    authors: Schiele F,Vuillemenot A,Kramarz P,Kieffer Y,Anguenot T,Bernard Y,Bassand JP

    更新日期:1995-09-01 00:00:00

  • High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulant.

    abstract::The relationship between thrombocytopenia and the level of anticardiolipin antibodies (aCL) and/or the existence of lupus anticoagulant (LA) ware studied in 146 patients with systemic lupus erythematosus (SLE). These patients were divided into six groups: A, those LA positive with a high level of aCL (>10 U/ml) (10 ca...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199805)58:1<55::aid-ajh10>

    authors: Nojima J,Suehisa E,Kuratsune H,Machii T,Toku M,Tada H,Yamaguti K,Koike T,Kanakura Y,Kitani T,Amino N

    更新日期:1998-05-01 00:00:00

  • Abnormal erythrocyte metabolism in hepatic disease: effect of NADP repletion.

    abstract::Erythrocytes from ten patients with severe liver disease displayed low methylene blue-stimulated hexose monophosphate (HMP) shunt activity and glucose recycling despite elevated total glucose consumption when compared to controls. Heinz body formation was increased and reduced glutathione concentration significantly d...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830060403

    authors: Smith JR,Kay NE,Gottlieb AJ,Oski FA

    更新日期:1979-01-01 00:00:00